This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Cao, J. Articles by Lai, J. Search for Related Content PubMed PubMed Citation Articles by Cao, J. Articles by Lai, J. Social Bookmarking                   What's this?

Effects of Parenteral Nutrition Without and With Growth Hormone on Growth Hormone/Insulin-Like Growth Factor-1 Axis After Hepatectomy in Hepatocellular Carcinoma With Liver Cirrhosis

Jie Cao, MD^*, Shi-Min Luo, MD^*, Lijian Liang, MD and Jiaming Lai, MD

From the ^* Department of General Surgery, Affiliated Guangzhou First Municipal People's Hospital, Guangzhou Medical College, Guangzhou, China; and the Department of Hepatobiliary Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

Correspondence: Jie Cao, MD, Professor, Department of General Surgery, Affiliated Guangzhou First Municipal People's Hospital, Guangzhou Medical College, 1 Panfu Lu, Guangzhou 510180, Guangdong Province, China. Electronic mail may be sent to ljq77{at}medmail.com.cn.

Background: Complex alterations in the growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis are thought to play an important role in the protein catabolism that complicates major surgical procedures. The aim of this study was to evaluate the potential roles of recombinant human growth hormone (rhGH) therapy after hepatectomy in hepatocellular carcinoma (HCC) with liver cirrhosis, and to investigate whether postoperative administration of rhGH increases the risk of tumor recurrences. Methods: Twenty-four patients with HCC in the setting of cirrhosis who underwent hepatectomy were randomly divided into 2 groups: parenteral nutrition (PN) group (n = 12) and rhGH + parenteral nutrition group (n = 12). Liver function, serum GH, IGF-1, and IGF binding protein-3 (IGFBP-3) were measured before operation, at postoperative days (POD) 1 and 6. IGF-1 and IGFBP-3 mRNA in liver tissue was measured by reverse transcriptase polymerase chain reaction. Liver Ki67 immunohistochemistry staining was studied. At the same time, 12 patients with cholelithiasis or liver hemangioma who underwent operation were segregated as a normal control. Results: On POD 6, compared with the PN group, serum prealbumin, GH, IGF-1, IGFBP-3, hepatic IGF-1 mRNA, IGFBP-3 mRNA, and liver Ki67 LI were higher in rhGH + PN group. The 6- and 12-month tumor-free survival rates, a median tumor-free survival time, were not different between the PN and rhGH + PN group. Conclusions: rhGH + PN can ameliorate changes in the GH/IGF-1 axis after hepatectomy for HCC in the setting of cirrhosis.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?